StockData
Bioxytran, Inc logo

Bioxytran, Inc (BIXT) KPIs and segments

BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.02−0.00 (-3.95%)

Close on Oct 19, 2026Market cap $2.56MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Bioxytran's business

Coming soon

This tab will track the numbers specific to Bioxytran's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?